ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0019

Use of High-plex Data Reveals Novel Insights into the Temporal Artery Processus of Giant Cell Arteritis

Simon Parreau1, Elsa Molina2, Stéphanie Dumonteil1, Radjiv Goulabchand3, Thomas Naves4, Melanie Bois5, Anne-Laure Fauchais1, Eric Liozon6, Marie-Odile Jauberteau4, Cornelia M. Weyand7 and Kim-Heang Ly1, 1Dupuytren Hospital, Limoges, France, 2Next Generation Sequencing Core, Salk Institute for Biological Studies, La Jolla, CA, 3University of California San Diego, La Jolla, CA, 4INSERM U1308, Limoges, France, 5Mayo Clinic, Rochester, MN, 6Department of Internal Medicine, University Hospital of Limoges, Limoges Cedex, Limoges, France, 7Mayo Clinic School of Medicine and Stanford University, Rochester, MN

Meeting: ACR Convergence 2023

Keywords: genomics, giant cell arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0013–0039.5) Genetics, Genomics & Proteomics Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Uncover the key coding genes to define new biomarkers or pathways associated with GCA by performing the first in situ spatial profiling characterization of molecular actors involved in temporal arteries from GCA patients in comparison to normal arteries.

Methods: From human formalin-fixed paraffin-embedded temporal artery biopsy samples (GCA n=9; controls n=7), we performed a whole transcriptome analysis by using NanoString GeoMx Digital Spatial Profiler (DSP) (2). A total of 59 individual regions of interest (ROIs) were created within each of the 4 layers for each individual artery. After ROIs collection and library construction, samples were sequenced on the Illumina NovaSeq 6000 platform and reads were digitally quantified and normalized using GeoMx DSP Data Analysis software. Differential expressed genes (DEGs) (fold change >2 or < -2, p-adjusted < 0.05) were compared for each layer, to build a spatial and pharmacogenomic network in disease course.

Results: Overall, we found that most of the transcriptome studied (12076 genes) was upregulated in GCA arteries. Precisely, 350, 340, 142 and 5 DEGs were found in intima, media, adventitia, and perivascular tissue respectively. Enrichment analysis highlighted that inflammation/immune-related functions and vascular remodeling were significantly limited to intima and media layers. Upregulated immune-related functions concerned macrophage differentiation & T cell, B cell, complement activations. Regarding vascular remodeling pathways, we found an upregulation of: (i) collagen metabolic process and fibroblast proliferation concerning the 3 artery layers, (ii) angiogenesis & epithelial cell migration in intima and media layers, (iii) smooth muscle cell proliferation & ossification in intima layer. Our pharmacogenomic network analysis identified genes that could potentially be targeted by immunosuppressive drugs currently approved or new immunotherapies.

Conclusion: Our findings provide the first in situ spatial profiling characterization of molecular actors involved in GCA which is essential for the discovery of potential new therapeutic targets to cure this disease. The differential spatial upregulation of genes involved in inflammatory process and vascular remodeling suggests a differential chronological involvement of each layer of the artery.


Disclosures: S. Parreau: NanoString Technologies Inc., Seattle, WA, 5; E. Molina: NanoString Technologies Inc., Seattle, WA, 5; S. Dumonteil: None; R. Goulabchand: None; T. Naves: None; M. Bois: None; A. Fauchais: None; E. Liozon: None; M. Jauberteau: None; C. Weyand: None; K. Ly: None.

To cite this abstract in AMA style:

Parreau S, Molina E, Dumonteil S, Goulabchand R, Naves T, Bois M, Fauchais A, Liozon E, Jauberteau M, Weyand C, Ly K. Use of High-plex Data Reveals Novel Insights into the Temporal Artery Processus of Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/use-of-high-plex-data-reveals-novel-insights-into-the-temporal-artery-processus-of-giant-cell-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-high-plex-data-reveals-novel-insights-into-the-temporal-artery-processus-of-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology